Pfizer
AHS Announces Headache and Migraine Competitive Grant Program
The American Headache Society is partnering with Pfizer to launch the Headache and Migraine Competitive Grant ...
JUNE 6, 2024
FDA Approves CGRP Nasal Spray for Acute Migraine Treatment
The FDA approved zavegepant (Zavzpret, Pfizer) as the first calcitonin gene–related peptide (CGRP) receptor ...
MARCH 14, 2023
Tofacitinib Data Shed Light on DVT/PE Rates
Clinicians and patients with ulcerative colitis, rheumatoid arthritis, psoriatic arthritis or ankylosing ...
SEPTEMBER 30, 2020
Ixifi, a Biosimilar of Remicade, Receives Approval
FDA approves another biosimilar of Remicade. Ixifi has all of the same indications.
DECEMBER 21, 2017
Load more